No. 2016-CC-1767 Precedential Processed

Jackson v. Janssen Pharmaceuticals, Inc.

Louisiana Supreme Court · Filed January 9, 2017 · 208 So. 3d 881

Opinion text

JOHNSON, Chief Justice, would grant the writ application. hi find the district court correctly denied defendants’ motion for summary judgment in this case. I agree with the district court that a disputed issue of material fact exists concerning whether plaintiffs prescribing physicians were adequately warned of Risperdal’s potential side effects, particularly in non-schizophrenic, elderly patients such as Ms. Jackson. Additionally, as plaintiffs effectively argue, the credibility of the prescribing physicians is clearly at issue in this case thereby rendering summary judgment premature. Accordingly, I would grant the plaintiffs’ writ application.